Bioorganic and Medicinal Chemistry

Journal

Publication Venue For

  • Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells.  26:2428-2436. 2018
  • The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.  24:6119-6130. 2016
  • IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.  23:602-611. 2015
  • A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: Design of potent new ligands.  22:95-104. 2014
  • Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.  22:178-185. 2014
  • 6-Oxo and 6-thio purine analogs as antimycobacterial agents.  21:1685-1695. 2013
  • Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: The hydrophobic side chain influences type A subtype selectivity.  20:4582-4589. 2012
  • Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl) methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.  20:4590-4597. 2012
  • Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.  19:7120-7128. 2011
  • Palmerolide macrolides from the Antarctic tunicate Synoicum adareanum.  19:6608-6614. 2011
  • CNS and antimalarial activity of synthetic meridianin and psammopemmin analogs.  19:5756-5762. 2011
  • Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.  19:2557-2564. 2011
  • Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.  18:4056-4066. 2010
  • Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.  18:3403-3412. 2010
  • Synthesis of deoxygenated α(1 → 5)-linked arabinofuranose disaccharides as substrates and inhibitors of arabinosyltransferases of Mycobacterium tuberculosis.  17:872-881. 2009
  • Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines.  16:2541-2549. 2008
  • Disaccharide analogs as probes for glycosyltransferases in Mycobacterium tuberculosis.  15:5629-5650. 2007
  • Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.  13:4842-4850. 2005
  • Synthesis and evaluation of esters and carbamates to identify critical functional groups for esterase-specific metabolism.  11:3237-3244. 2003
  • Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: Modifications of essential pyrrolidinone ring substituents.  11:2739-2749. 2003
  • Studies on n-octyl-5-(α-D-arabinofuranosyl)-β-D-galactofuranosides for mycobacterial glycosyltransferase activity.  10:923-928. 2002
  • Studies on (β,1→5) and (β,1→6) linked octyl Galf disaccharides as substrates for mycobacterial galactosyltransferase activity.  9:3129-3143. 2001
  • Studies on α(1→5) linked octyl arabinofuranosyl disaccharides for mycobacterial arabinosyl transferase activity.  9:3145-3151. 2001
  • Hydrophobic benzoic acids as inhibitors of influenza neuraminidase.  7:2487-2497. 1999
  • Improved synthesis of the bifunctional chelating agent 1,4,7,10- tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tris(acetic acid)cyclododecane (PA-DOTA).  7:2313-2320. 1999
  • Studies on β-D-Gal(f)-(1→4)-α-L-Rha(p) octyl analogues as substrates for mycobacterial galactosyl transferase activity.  7:2407-2413. 1999
  • Stereoselective synthesis of a conformationally defined cyclohexyl carnitine analogue that binds CPT-1 with high affinity.  7:1505-1511. 1999
  • Synthesis and properties of some novel anti-calmodulin drugs.  7:1559-1565. 1999
  • Synthesis of 2-[6-(2,4-Dinitrophenoxy)hexyl]oxiranecarboxylic acid: A selective carnitine palmitoyltransferase-1 inhibitor.  6:2133-2138. 1998

    • International Standard Serial Number (issn)

  • 0968-0896

    • Electronic International Standard Serial Number (eissn)

  • 1464-3391